It takes two to tango: NAD+ and sirtuins in aging/longevity control

Shin-Ichiro Imai, Leonard Guarente, Shin-Ichiro Imai, Leonard Guarente

Abstract

The coupling of nicotinamide adenine dinucleotide (NAD+) breakdown and protein deacylation is a unique feature of the family of proteins called 'sirtuins.' This intimate connection between NAD+ and sirtuins has an ancient origin and provides a mechanistic foundation that translates the regulation of energy metabolism into aging and longevity control in diverse organisms. Although the field of sirtuin research went through intensive controversies, an increasing number of recent studies have put those controversies to rest and fully established the significance of sirtuins as an evolutionarily conserved aging/longevity regulator. The tight connection between NAD+ and sirtuins is regulated at several different levels, adding further complexity to their coordination in metabolic and aging/longevity control. Interestingly, it has been demonstrated that NAD+ availability decreases over age, reducing sirtuin activities and affecting the communication between the nucleus and mitochondria at a cellular level and also between the hypothalamus and adipose tissue at a systemic level. These dynamic cellular and systemic processes likely contribute to the development of age-associated functional decline and the pathogenesis of diseases of aging. To mitigate these age-associated problems, supplementation of key NAD+ intermediates is currently drawing significant attention. In this review article, we will summarize these important aspects of the intimate connection between NAD+ and sirtuins in aging/longevity control.

Conflict of interest statement

SI is a co-founder of Metro Midwest Biotech. LG is a founder of Elysium Health and consults for GSK, Chronos (Oxford), and Segterra.

Figures

Figure 1
Figure 1
Comparison of NAD+ biosynthetic pathways between yeast/invertebrates and mammals. Left panel: NAD+ biosynthetic pathways in the budding yeast Saccharomyces cerevisiae and invertebrates. The pathways from NIC, NA, and NR and the de novo pathway from tryptophan are shown. Right panel: NAD+ biosynthetic pathways in mammals. In mammals, NIC is a predominant NAD+ precursor. NA, NR, and tryptophan can also be utilized to synthesize NAD+. The de novo pathway and the NAD+ biosynthetic pathway from NA are evolutionarily conserved, whereas the NAD+ biosynthetic pathway from NIC is mediated by NAMPT. In this figure, only sirtuins are shown among multiple NAD+-consuming enzymes that break NAD+ into nicotinamide and ADP-ribose. Mammals have two NR kinases (Nrk1 and 2) and ecto-5′-nucleotidase CD73 to produce NMN and NR, respectively. NA, nicotinic acid; NAD+, nicotinamide adenine dinucleotide; NAMPT, nicotinamide phosphoribosyltransferase; NIC, nicotinamide; NR, nicotinamide riboside; Nrk1, nicotinamide ribose kinase 1; Npt1, nicotinic acid phosphoribosyltransferase; Nma1, 2, nicotinic acid mononucleotide adenylyltransferase 1, 2; Nnt1, nicotinamide-N-methyltransferase; Npt, nicotinic acid phosphoribosyltransferase; NMNAT, NMN adenylyltransferase; NNMT, nicotinamide-N-methyltransferase; NaMN, nicotinic acid mononucleotide; NMN, nicotinamide mononucleotide; Pho5, 8, phosphatase 5, 8; Pnp1, purine nucleoside phosphorylase; Pnc1, nicotinamidase; Qpt, quinolinic acid phosphoribosyltransferase; Qns1, NAD synthetase; Qpt1, quinolinic acid phosphoribosyltransfease; Urh1, uridine hydrolase.
Figure 2
Figure 2
Responses of NAD+ biosynthetic enzymes and sirtuins to nutritional and environmental cues in aging/longevity control. (a) Responses of PNC1 and sirtuins in budding yeast Saccharomyces cerevisiae and invertebrates (worms and flies) to caloric restriction (CR) and stress. When PNC1 levels increase in response to CR or stress in these organisms, the NAD+ biosynthetic flux increases and nicotinamide levels decrease, both contributing to the enhancement of sirtuin activity. (b) Responses of NAMPT and sirtuins in mammals to CR, exercise, and stress. Upregulation of NAMPT activates sirtuins primarily through the increase in NAD+ biosynthesis because nicotinamide levels are normally much lower in mammals, compared to yeast. CR, caloric restriction; NAD+, nicotinamide adenine dinucleotide; NAMPT, nicotinamide phosphoribosyltransferase.
Figure 3
Figure 3
Circadian regulation of NAD+ biosynthesis and metabolism by NAMPT and sirtuins. Nampt is one of the SIRT1/CLOCK/BMAL1-regulated circadian genes, and SIRT1 and NAMPT comprise a novel circadian regulatory feedback loop, producing the circadian oscillation of NAD+. This circadian oscillation of NAD+ drives SIRT1, SIRT3, and SIRT6 activities. SIRT1 feedbacks the key circadian transcription factors CLOCK/BMAL and regulates genes related to peptide and cofactor biosynthesis in the liver. SIRT1 also regulates Bmal1 expression through PGC-1α in the suprachiasmatic nucleus. SIRT6 controls the chromatin recruitment of CLOCK/BMAL1 and SREBP1 and regulates genes related to lipid and carbohydrate metabolism. SIRT3 regulates oxidative metabolism in mitochondria through circadian deacetylation of mitochondrial oxidative enzymes. All these circadian activity changes of sirtuins produce robust metabolic outputs in many different tissues and organs. NAD+, nicotinamide adenine dinucleotide; NAMPT, nicotinamide phosphoribosyltransferase.
Figure 4
Figure 4
Regulation of the functional connection between NAD+ and sirtuins. There are at least three levels of regulation: (1) regulation of NAD+ biosynthesis, particularly mediated by NAMPT, (2) modulation of sirtuin activity, including inhibition by nicotinamide and NADH and activation of SIRT6 by long-chain fatty acids, and (3) competition with other NAD+-consuming enzymes, such as PARPs and CD38/157 ectoenzymes. See details in text. NAD+, nicotinamide adenine dinucleotide; NAMPT, nicotinamide phosphoribosyltransferase; PARPs, poly-ADP-ribose polymerases.
Figure 5
Figure 5
Importance of the communication between the nucleus and mitochondria at a cellular level (a) and between the hypothalamus and adipose tissue at a systemic level (b) in aging/longevity control. See details in text.

References

    1. Imai, S., Armstrong, C. M., Kaeberlein, M. & Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795–800 (2000).
    1. Canto, C., Menzies, K. J. & Auwerx, J. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22, 31–53 (2015).
    1. Imai, S. & Guarente, L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 24, 464–471 (2014).
    1. Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E. & Mann, M. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 15, 536–550 (2014).
    1. Wagner, G. R. & Hirschey, M. D. Nonenzymatic protein acylation as a carbon stress regulated by sirtuin deacylases. Mol Cell. 54, 5–16 (2014).
    1. Feldman, J. L., Dittenhafer-Reed, K. E. & Denu, J. M. Sirtuin catalysis and regulation. J. Biol. Chem. 287, 42419–42427 (2012).
    1. Miller, E. S. et al. Complete genome sequence of the broad-host-range vibriophage KVP40: comparative genomics of a T4-related bacteriophage. J. Bacteriol. 185, 5220–5233 (2003).
    1. Yoon, M. J. et al. SIRT1-Mediated eNAMPT secretion from adipose tissue regulates hypothalamic NAD(+) and function in mice. Cell Metab. 21, 706–717 (2015).
    1. Imai, S. The NAD world: a new systemic regulatory network for metabolism and aging—Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem. Biophys. 53, 65–74 (2009).
    1. Imai, S. ‘Clocks’ in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging. Biochim. Biophys. Acta. 1804, 1584–1590 (2010).
    1. Imai, S. Dissecting systemic control of metabolism and aging in the NAD World: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett. 585, 1657–1662 (2011).
    1. Imai, S. & Yoshino, J. The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obes. Metab. 2013; 15: 26–33.
    1. Gazzaniga, F., Stebbins, R., Chang, S. Z., McPeek, M. A. & Brenner, C. Microbial NAD metabolism: lessons from comparative genomics. Microbiol. Mol. Biol. Rev. 73, 529–541 (2009).
    1. Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O. & Sinclair, D. A. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423, 181–185 (2003).
    1. Balan, V. et al. Life span extension and neuronal cell protection by Drosophila nicotinamidase. J. Biol. Chem. 283, 27810–27819 (2008).
    1. van der Horst, A., Schavemaker, J. M., Pellis-van Berkel, W. & Burgering, B. M. The Caenorhabditis elegans nicotinamidase PNC-1 enhances survival. Mech Ageing Dev. 128, 346–349 (2007).
    1. Feldman, J. L. et al. Kinetic and structural basis for acyl-group selectivity and NAD(+) dependence in sirtuin-catalyzed deacylation. Biochemistry 54, 3037–3050 (2015).
    1. Kaeberlein, M., McVey, M. & Guarente, L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570–2580 (1999).
    1. Rogina, B. & Helfand, S. L. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. USA 101, 15998–16003 (2004).
    1. Tissenbaum, H. A. & Guarente, L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227–230 (2001).
    1. Burnett, C. et al. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482–485 (2011).
    1. Herranz, D. et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat. Commun. 1, 3 (2010).
    1. Banerjee, K. K. et al. dSir2 in the adult fat body, but not in muscles, regulates life span in a diet-dependent manner. Cell Rep. 2, 1485–1491 (2012).
    1. Kanfi, Y. et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 483, 218–221 (2012).
    1. Mouchiroud, L. et al. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154, 430–441 (2013).
    1. Rizki, G. et al. The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO. PLoS Genet. 7, e1002235 (2011).
    1. Satoh, A. et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 18, 416–430 (2013).
    1. Schmeisser, K. et al. Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat. Chem. Biol. 9, 693–700 (2013).
    1. Stumpferl, S. W. et al. Natural genetic variation in yeast longevity. Genome Res. 22, 1963–1973 (2012).
    1. Viswanathan, M. & Guarente, L. Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes. Nature 477, E1–E2 (2011).
    1. Satoh, A. & Imai, S. Systemic regulation of mammalian ageing and longevity by brain sirtuins. Nat. Commun. 5, 4211 (2014).
    1. Giblin, W., Skinner, M. E. & Lombard, D. B. Sirtuins: guardians of mammalian healthspan. Trends Genet. 30, 271–286 (2014).
    1. Longo, V. D. et al. Interventions to slow aging in humans: are we ready? Aging Cell 14, 497–510 (2015).
    1. Sharples, A. P. et al. Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake. Aging Cell 14, 511–523 (2015).
    1. Lin, S.-J., Defossez, P.-A. & Guarente, L. Life span extension by calorie restriction in S. cerevisiae requires NAD and SIR2. Science 289, 2126–2128 (2000).
    1. Kaeberlein, M. et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310, 1193–1196 (2005).
    1. Bogan, K. L. et al. Identification of Isn1 and Sdt1 as glucose- and vitamin-regulated nicotinamide mononucleotide and nicotinic acid mononucleotide 5′-nucleotidases responsible for production of nicotinamide riboside and nicotinic acid riboside. J. Biol. Chem. 284, 34861–34869 (2009).
    1. Lu, S. P., Kato, M. & Lin, S. J. Assimilation of endogenous nicotinamide riboside is essential for calorie restriction-mediated life span extension in Saccharomyces cerevisiae. J. Biol. Chem. 284, 17110–17119 (2009).
    1. Belenky, P. et al. Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Cell 129, 473–484 (2007).
    1. Moroz, N. et al. Dietary restriction involves NAD(+)-dependent mechanisms and a shift toward oxidative metabolism. Aging Cell 13, 1075–1085 (2014).
    1. Garten, A., Petzold, S., Korner, A., Imai, S. & Kiess, W. Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol. Metab. 20, 130–138 (2009).
    1. Imai, S. Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases. Curr. Pharm. Des. 15, 20–28 (2009).
    1. Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M. & Sassone-Corsi, P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324, 654–657 (2009).
    1. Peek, C. B. et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science 342, 1243417 (2013).
    1. Ramsey, K. M. et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651–654 (2009).
    1. Revollo, J. R., Grimm, A. A. & Imai, S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 279, 50754–50763 (2004).
    1. Yang, H. et al. Nutrient-sensitive mitochondrial NAD(+) levels dictate cell survival. Cell 130, 1095–1107 (2007).
    1. Costford, S. R. et al. Skeletal muscle NAMPT is induced by exercise in humans. Am. J. Physiol. Endocrinol. Metab. 298, E117–E126 (2010).
    1. Fulco, M. et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell. 14, 661–673 (2008).
    1. Nakagawa, T., Lomb, D. J., Haigis, M. C. & Guarente, L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560–570 (2009).
    1. Song, J. et al. Nicotinamide phosphoribosyltransferase is required for the calorie restriction-mediated improvements in oxidative stress, mitochondrial biogenesis, and metabolic adaptation. J. Gerontol. A Biol. Sci. Med. Sci. 69, 44–57 (2014).
    1. Chang, H. C. & Guarente, L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 153, 1448–1460 (2013).
    1. Masri, S. et al. Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism. Cell 158, 659–672 (2014).
    1. Zhang, G. et al. Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH. Nature 497, 211–216 (2013).
    1. Benedict, C. et al. Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt/visfatin/PBEF): impact of sleep loss and relation to glucose metabolism. J. Clin. Endocrinol. Metab. 97, E218–E222 (2012).
    1. Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528–536 (2011).
    1. Gomes, A. P. et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624–1638 (2013).
    1. Stein, L. R. & Imai, S. Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging. EMBO J. 33, 1321–1340 (2014).
    1. Dahl, T. B. et al. Intracellular nicotinamide phosphoribosyltransferase protects against hepatocyte apoptosis and is down-regulated in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 95, 3039–3047 (2010).
    1. Ghosh, D., Levault, K. R. & Brewer, G. J. Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons. Aging Cell 13, 631–640 (2014).
    1. Hsu, C. P., Oka, S., Shao, D., Hariharan, N. & Sadoshima, J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ. Res. 105, 481–491 (2009).
    1. Jukarainen, S. et al. Obesity is associated with low NAD/SIRT pathway expression in adipose tissue of BMI-discordant monozygotic twins. J. Clin. Endocrinol. Metab. 101, 275–283 (2015).
    1. Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M. & Sinclair, D. A. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277, 45099–45107 (2002).
    1. Bernofsky, C. Physiology aspects of pyridine nucleotide regulation in mammals. Mol. Cell. Biochem. 33, 135–143 (1980).
    1. Catz, P. et al. Simultaneous determination of myristyl nicotinate, nicotinic acid, and nicotinamide in rabbit plasma by liquid chromatography-tandem mass spectrometry using methyl ethyl ketone as a deproteinization solvent. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 829, 123–135 (2005).
    1. Jacobson, E. L., Dame, A. J., Pyrek, J. S. & Jacobson, M. K. Evaluating the role of niacin in human carcinogenesis. Biochimie 77, 394–398 (1995).
    1. Lin, S.-J., Ford, E., Haigis, M., Liszt, G. & Guarente, L. Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 18, 12–16 (2004).
    1. Madsen, A. S. et al. Investigating the sensitivity of NAD+-dependent sirtuin deacylation activities to NADH. J. Biol. Chem. 291, 7128–7141 (2016).
    1. Schmidt, M. T., Smith, B. C., Jackson, M. D. & Denu, J. M. Co-enzyme specificity of Sir2 protein deacetylases: Implications for physiological regulation. J. Biol. Chem. 279, 40122–40129 (2004).
    1. Feldman, J. L., Baeza, J. & Denu, J. M. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J. Biol. Chem. 288, 31350–31356 (2013).
    1. Bai, P. et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461–468 (2011).
    1. Barbosa, M. T. et al. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. Faseb J. 21, 3629–3639 (2007).
    1. Escande, C. et al. Flavonoid apigenin is an inhibitor of the NAD+ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes 62, 1084–1093 (2013).
    1. Brunet, A. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011–2015 (2004).
    1. Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1a and SIRT1. Nature 434, 113–118 (2005).
    1. Papa, L. & Germain, D. SirT3 regulates the mitochondrial unfolded protein response. Mol. Cell. Biol. 34, 699–710 (2014).
    1. Zhang, H. et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science, pii: aaf2693; doi:10.1126/science.aaf2693 (28 April 2016).
    1. Houtkooper, R. H. et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497, 451–457 (2013).
    1. Satoh, A., Brace, C. S., Rensing, N. & Imai, S. Deficiency of Prdm13, a dorsomedial hypothalamus-enriched gene, mimics age-associated changes in sleep quality and adiposity. Aging Cell 14, 209–218 (2015).

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi